DB16692InvestigationalVaccines
Axalimogene filolisbac is under investigation in clinical trial NCT02853604 (Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer).
- Also known as
- Adxs hpv · Adxs-hpv · Live, attenuated listeria monocytogenes bacteria, expressing human papilloma virus type 16-e7 tumor antigen · Raligize
- Code names
- ADXS 11-001
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Axalimogene filolisbac, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account